Corticosteroids and osteoporosis;Corticoides y osteoporosis

Actas Dermo-Sifiliograficas

Volumn 98, Issue 8, 2007, Pages 526-530

  García Bustínduy, Marta ^a   Gantes, M A ^a  

^a HOSPITAL UNIVERSITARIO DE CANARIAS   (Spain)

Author keywords

Bisphosphonates; Corticosteroids; Osteoporosis

Indexed keywords

ALENDRONIC ACID; ANTICONVULSIVE AGENT; BISPHOSPHONIC ACID DERIVATIVE; CALCIUM; CORTICOSTEROID; PREDNISONE; RISEDRONIC ACID; VITAMIN D;

AGE DISTRIBUTION; ARTICLE; BONE DENSITY; CLINICAL PROTOCOL; CORTICOSTEROID INDUCED OSTEOPOROSIS; DRUG DOSE REGIMEN; DRUG SAFETY; FRAGILITY FRACTURE; HIGH RISK PATIENT; HIP FRACTURE; HORMONE SUBSTITUTION; HUMAN; HYPERTHYROIDISM; LONG TERM CARE; LOW DRUG DOSE; MENOPAUSE; OSTEOPOROSIS; RHEUMATOID ARTHRITIS; RISK ASSESSMENT; SEX DIFFERENCE;

EID: 35348943267     PISSN: 00017310     EISSN: 15782190     Source Type: Journal    
DOI: 10.1016/S0001-7310(07)70127-8     Document Type: Article

References (20)

1. Sulzberger MB, Witten VH. Effect of topically applied compound F in selected dermatoses. J Invest Dermatol. 1952;19:101-2.
2. Brazzini B, Pimpinelli N. New and established topical corticosteroids in Dermatology. Clinical pharmacology and therapeutic use. Am J Clin Dermatol. 2002;3:47-58.
3. Markham A, Bryson HM. Deflazacort. A review of its pharmacological properties and therapeutic efficacy. Drugs. 1995;50:317-33.
4. Gennari C. Differential effect of glucocorticoids on calcium absorption and bone mass. Br J Rheumatol. 1993;32 Suppl 2:S11-4.
5. Robertson DB, Maibach HI. Adverse systemic effects of TCS. En: Maibach HI, Surber C, editors. TCS. Basel: Karger; 1992. p. 163-9.
6. Raisz LG. Pathogenesis of osteoporosis: concepts, conflicts and prospects. J Clin Invest. 2005;115:3318-25.
7. NIH Consensus Development Panel on osteoporosis prevention, diagnosis and therapy. Osteoporosis prevention, diagnosis, and therapy. JAMA. 2001;285:785-95.
8. Parfitt AM, Villanueva AR, Foldes J, Rao DS. Relations between histologic indexes of bone formation: implications for the pathogenesis of spinal osteoporosis. J Bone Miner Res. 1995;10:466-73.
9. EPOS Group. Incidence of vertebral fracture in Europe: results from the European Prospective Osteoporosis Study (EPOS). J Bone Miner Res. 2002;17:716-24.
10. MacAdams MR, White RH, Chipps BE. Reduction of serum testosterone levels during chronic glucocorticoid therapy. Ann Intern Med. 1986;104:648-51.
11. Chyun YS, Kream BE, Raisz LG. Cortisol decreases bone formation by inhibiting perosteal cell proliferation. Endocrinology. 1984;114:477-80.
12. Sambrook PN, Eisman JA, Champion GD, Pocock NA. Sex hormone status and osteoporosis in postmenopausal women with rheumatoid arthritis. Arthritis Rheum. 1988;31:973-8.
13. Klein RG, Arnaud SB, Gallagher JC, Deluca HF, Riggs BL. Intestinal calcium absorption in exogenous hypercortisonism. Role of 25-hydroxyvitamin D and corticosteroid dose. J Clin Invest. 1977;60:253-9.
14. Lukert BP, Raixz LG. Glucocorticoid-induced osteoporosis: Pathogenesis and management. Ann Intern Med. 1990;112:352-64.
15. Laan RF, van Riel PL, van de Putte LB, van Erning LJ, van't Hof MA, Lemmens JA. Low-dose prednisone induces rapid reversible axial bone loss in patients with rheumatoid arthritis. A randomized, controlled study. Ann Intern Med. 1993;119: 963-8.
16. Cooper C, Coupland C, Mitchell M. Rheumatoid arthritis, corticosteroid therapy and hip fracture. Ann Rheum Dis. 1995;54:49-52.
17. Hall GM, Spector TD, Delmas PD. Markers of bone metabolism in postmenopausal women with rheumatoid arthritis. Effects of corticosteroids and hormone replacement therapy. Arthritis Rheum. 1995;38:902-6.
18. Morrison NA, Qi JC, Tokita A, Kelly PJ, Crofts L, Nguyen TV, et al. Prediction of bone density from vitamin D receptor alleles. Nature. 1994;367:284-7.
19. American College of Rheumatology Ad Hoc Committee on Glucocorticoid- induced Osteoporosis. Recommendations for the prevention and treatment of glucocorticoid-induced osteoporosis: 2001 update. Arthritis Rheum. 2001;44:1496-503.
20. Summey BT, Yosipovitch G. Glucocorticoid-induced bone loss in dermatologic patients. Arch Dermatol. 2006;142:82-90.